Tiemin Pei

965 total citations
10 papers, 384 citations indexed

About

Tiemin Pei is a scholar working on Cancer Research, Surgery and Molecular Biology. According to data from OpenAlex, Tiemin Pei has authored 10 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Tiemin Pei's work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer-related molecular mechanisms research (5 papers) and RNA modifications and cancer (4 papers). Tiemin Pei is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer-related molecular mechanisms research (5 papers) and RNA modifications and cancer (4 papers). Tiemin Pei collaborates with scholars based in China. Tiemin Pei's co-authors include Ruipeng Song, Shangha Pan, Boshi Sun, Qinghui Meng, Desen Liang, Tongsen Zheng, Dalong Yin, Hongchi Jiang, Yingjian Liang and Jiabei Wang and has published in prestigious journals such as Journal of Hepatology, Cancer Letters and Oncotarget.

In The Last Decade

Tiemin Pei

10 papers receiving 381 citations

Peers

Tiemin Pei

MB

CR

CB

SURGE

ONCOL

Lianxin Liu China

Naveenkumar Perumal United States

Almudena Chaves Perez United States

Peace Mabeta South Africa

Leilei Li China

Zunqi Hu China

Manendra Babu Lankadasari India

Yunxia Lv China

Michele Pietrafesa Italy

Luana Tomaipitinca Italy

Lianxin Liu China

Tiemin Pei

268 ×1.1

MB

87 ×0.8

CR

30 ×0.3

CB

29 ×0.3

SURGE

96 ×1.2

ONCOL

Citations per year, relative to Tiemin Pei Tiemin Pei (= 1×) peers Lianxin Liu

Countries citing papers authored by Tiemin Pei

Since Specialization

Citations

This map shows the geographic impact of Tiemin Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiemin Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiemin Pei more than expected).

Fields of papers citing papers by Tiemin Pei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiemin Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiemin Pei. The network helps show where Tiemin Pei may publish in the future.

Co-authorship network of co-authors of Tiemin Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Tiemin Pei. A scholar is included among the top collaborators of Tiemin Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiemin Pei. Tiemin Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Xiao, Peng, Qinghui Meng, Qi Liu, et al.. (2023). IGF2BP1-mediated N6-methyladenosine modification promotes intrahepatic cholangiocarcinoma progression. Cancer Letters. 557. 216075–216075. 20 indexed citations

2.

Pei, Tiemin, et al.. (2020). Dysregulation of the miR-148a–GLUT1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinoma. Oncogenesis. 9(2). 19–19. 26 indexed citations

3.

Xiao, Peng, et al.. (2020). COUP-TFII promotes metastasis and epithelial-to-mesenchymal transition through upregulating Snail in human intrahepatic cholangiocarcinoma. Acta Biochimica et Biophysica Sinica. 52(11). 1247–1256. 1 indexed citations

4.

Sun, Lixin, et al.. (2020). miR‐885‐5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma. Molecular Carcinogenesis. 59(12). 1371–1381. 27 indexed citations

5.

Pei, Tiemin, Fanzheng Meng, Peng Xiao, et al.. (2019). MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways. Journal of Hepatology. 72(4). 761–773. 73 indexed citations

6.

Pei, Tiemin, Qinghui Meng, Jihua Han, et al.. (2016). (−)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma. Oncotarget. 7(28). 43475–43491. 65 indexed citations

7.

Meng, Qinghui, et al.. (2016). Novel markers for circulating tumor stem cells in colorectal carcinoma.. PubMed. 8(10). 4233–4241. 9 indexed citations

8.

Zheng, Tongsen, Dalong Yin, Jiabei Wang, et al.. (2015). Selecting molecular therapeutic drug targets based on the expression profiles of intrahepatic cholangiocarcinomas and miRNA-mRNA regulatory networks. Oncology Reports. 35(1). 382–390. 3 indexed citations

9.

Pei, Tiemin, Yuejin Li, Jiabei Wang, et al.. (2015). YAP is a critical oncogene in human cholangiocarcinoma. Oncotarget. 6(19). 17206–17220. 118 indexed citations

10.

Lu, Zhaoyang, Jiabei Wang, Tongsen Zheng, et al.. (2014). FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling. BMC Cancer. 14(1). 783–783. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact